These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 15261226

  • 1. Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome.
    Stylli SS, Howes M, MacGregor L, Rajendra P, Kaye AH.
    J Clin Neurosci; 2004 Aug; 11(6):584-96. PubMed ID: 15261226
    [Abstract] [Full Text] [Related]

  • 2. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
    Ritz R, Müller M, Dietz K, Duffner F, Bornemann A, Roser F, Tatagiba M.
    J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
    [Abstract] [Full Text] [Related]

  • 3. [Photodynamic therapy of malignant brain tumors].
    Kostron H, Grunert V.
    Wien Klin Wochenschr; 1987 May 29; 99(11):389-92. PubMed ID: 2956770
    [Abstract] [Full Text] [Related]

  • 4. Photodynamic therapy of high grade glioma - long term survival.
    Stylli SS, Kaye AH, MacGregor L, Howes M, Rajendra P.
    J Clin Neurosci; 2005 May 29; 12(4):389-98. PubMed ID: 15925768
    [Abstract] [Full Text] [Related]

  • 5. Selective uptake of hematoporphyrin derivative into human cerebral glioma.
    Hill JS, Kaye AH, Sawyer WH, Morstyn G, Megison PD, Stylli SS.
    Neurosurgery; 1990 Feb 29; 26(2):248-54. PubMed ID: 2137904
    [Abstract] [Full Text] [Related]

  • 6. Differential expression of a novel voltage gated potassium channel--Kv 1.5 in astrocytomas and its impact on prognosis in glioblastoma.
    Arvind S, Arivazhagan A, Santosh V, Chandramouli BA.
    Br J Neurosurg; 2012 Feb 29; 26(1):16-20. PubMed ID: 21707241
    [Abstract] [Full Text] [Related]

  • 7. [Hematoporphyrin derivative-mediated photodynamic therapy for human nasopharyngeal carcinoma: a comparative study with CNE2 and C666-1 cell lines in vitro].
    Yang XM, Luo RC, Ma HJ, Li LB, Ding XM, Yan X, Lü CW, Zhou XP.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb 29; 27(2):165-7. PubMed ID: 17355926
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic effects of a new photosensitizer for photodynamic therapy of early head and neck cancer in relation to tissue concentration.
    Yoshida T, Tokashiki R, Ito H, Shimizu A, Nakamura K, Hiramatsu H, Tsukahara K, Shimizu S, Takata D, Okamoto I, Suzuki M.
    Auris Nasus Larynx; 2008 Dec 29; 35(4):545-51. PubMed ID: 18242905
    [Abstract] [Full Text] [Related]

  • 9. Photodynamic diagnosis and therapy and the brain.
    Kostron H.
    Methods Mol Biol; 2010 Dec 29; 635():261-80. PubMed ID: 20552352
    [Abstract] [Full Text] [Related]

  • 10. Photodynamic therapy of brain tumours.
    Kaye AH, Hill JS.
    Ann Acad Med Singap; 1993 May 29; 22(3 Suppl):470-81. PubMed ID: 8215203
    [Abstract] [Full Text] [Related]

  • 11. Time-resolved fluorescence spectroscopy of a hematoporphyrin derivative used for photodynamic therapy of cancer.
    Gottschlich S, Lippert BM, Schade W, Werner JA.
    Res Commun Mol Pathol Pharmacol; 1997 Nov 29; 98(2):237-40. PubMed ID: 9467832
    [Abstract] [Full Text] [Related]

  • 12. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
    Mizoe JE, Tsujii H, Hasegawa A, Yanagi T, Takagi R, Kamada T, Tsuji H, Takakura K, Organizing Committee of the Central Nervous System Tumor Working Group.
    Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):390-6. PubMed ID: 17459607
    [Abstract] [Full Text] [Related]

  • 13. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
    Razis E, Selviaridis P, Labropoulos S, Norris JL, Zhu MJ, Song DD, Kalebic T, Torrens M, Kalogera-Fountzila A, Karkavelas G, Karanastasi S, Fletcher JA, Fountzilas G.
    Clin Cancer Res; 2009 Oct 01; 15(19):6258-66. PubMed ID: 19789313
    [Abstract] [Full Text] [Related]

  • 14. Influence of epidermal growth factor on photodynamic therapy of glioblastoma cells in vitro.
    Fanuel-Barret D, Patrice T, Foultier MT, Vonarx-Coinsmann V, Robillard N, Lajat Y.
    Res Exp Med (Berl); 1997 Oct 01; 197(4):219-33. PubMed ID: 9440140
    [Abstract] [Full Text] [Related]

  • 15. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P, Saito T, Hama S, Arifin MT, Kajiwara Y, Yamasaki F, Hidaka T, Sugiyama K, Kurisu K.
    Cancer; 2007 Mar 01; 109(5):949-56. PubMed ID: 17262828
    [Abstract] [Full Text] [Related]

  • 16. Research progress of Hemoporfin--part one: preclinical study.
    Pu Y, Chen W, Yu Z.
    Photodiagnosis Photodyn Ther; 2012 Jun 01; 9(2):180-5. PubMed ID: 22594989
    [Abstract] [Full Text] [Related]

  • 17. A comparative study of 28 porphyrins and their abilities to localize in mammary mouse carcinoma: uroporphyrin I superior to hematoporphyrin derivative.
    El-Far M, Pimstone N.
    Prog Clin Biol Res; 1984 Jun 01; 170():661-72. PubMed ID: 6241706
    [Abstract] [Full Text] [Related]

  • 18. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA, Weingart JD, Parisi M, Hughes MA, Olivi A, Borzillary S, Alahakone D, Detorie NA, Wharam MD, Kleinberg L.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1133-9. PubMed ID: 15990019
    [Abstract] [Full Text] [Related]

  • 19. Phototoxicity of brain tissue in hematoporphyrin derivative treated mice.
    Rounds DE, Doiron DR, Jacques DB, Shelden CH, Olson RS.
    Prog Clin Biol Res; 1984 Jul 15; 170():613-28. PubMed ID: 6241701
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients.
    Wang LF, Fokas E, Bieker M, Rose F, Rexin P, Zhu Y, Pagenstecher A, Engenhart-Cabillic R, An HX.
    Oncol Rep; 2008 Jan 15; 19(1):151-6. PubMed ID: 18097589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.